Literature DB >> 21336694

The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.

Benjamin A Thomas1, Kjell Erlandsson, Marc Modat, Lennart Thurfjell, Rik Vandenberghe, Sebastien Ourselin, Brian F Hutton.   

Abstract

PURPOSE: Alzheimer's disease (AD) is the most common form of dementia. Clinically, it is characterized by progressive cognitive and functional impairment with structural hallmarks of cortical atrophy and ventricular expansion. Amyloid plaque aggregation is also known to occur in AD subjects. In-vivo imaging of amyloid plaques is now possible with positron emission tomography (PET) radioligands. PET imaging suffers from a degrading phenomenon known as the partial volume effect (PVE). The quantitative accuracy of PET images is reduced by PVEs primarily due to the limited spatial resolution of the scanner. The degree of PVE is influenced by structure size, with smaller structures tending to suffer from more severe PVEs such as atrophied grey matter regions. The aims of this paper were to investigate the effect of partial volume correction (PVC) on the quantification of amyloid PET and to highlight the importance of selecting an appropriate PVC technique.
METHODS: An improved PVC technique, region-based voxel-wise (RBV) correction, was compared against existing Van-Cittert (VC) and Müller-Gärtner (MG) methods using amyloid PET imaging data. Digital phantom data were produced using segmented MRI scans from a control subject and an AD subject. Typical tracer distributions were generated for each of the phantom anatomies. Also examined were 70 clinical PET scans acquired using [(18)F]flutemetamol. Volume of interest (VOI) analysis was performed for corrected and uncorrected images.
RESULTS: PVC was shown to improve the quantitative accuracy of regional analysis performed on amyloid PET images. Of the corrections applied, VC deconvolution demonstrated the worst recovery of grey matter values. MG PVC was shown to induce biases in some grey matter regions due to grey matter variability. In addition, white matter variability was shown to influence the accuracy of MG PVC in cortical grey matter and also cerebellar grey matter, a typical reference region for amyloid PET normalization in sporadic AD. RBV was shown to be more accurate than MG in terms of grey matter and white matter uptake. An increase in within-group variability after PVC was observed and is believed to be a genuine, more accurate representation of the data rather than a correction-induced error. The standardized uptake value ratio (SUVR) threshold for classifying subjects as either amyloid-positive or amyloid-negative was found to be 1.64 in the uncorrected dataset, rising to 2.25 after PVC.
CONCLUSION: Care should be taken when applying PVC to amyloid PET images. Assumptions made in existing PVC strategies can induce biases that could lead to erroneous inferences about uptake in certain regions. The proposed RBV PVC technique accounts for within-compartment variability, with the potential to reduce errors of this kind.

Entities:  

Mesh:

Year:  2011        PMID: 21336694     DOI: 10.1007/s00259-011-1745-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  30 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Positron emission tomography partial volume correction: estimation and algorithms.

Authors:  John A D Aston; Vincent J Cunningham; Marie-Claude Asselin; Alexander Hammers; Alan C Evans; Roger N Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2002-08       Impact factor: 6.200

3.  Using deconvolution to improve PET spatial resolution in OSEM iterative reconstruction.

Authors:  G Rizzo; I Castiglioni; G Russo; M G Tana; F Dell'Acqua; M C Gilardi; F Fazio; S Cerutti
Journal:  Methods Inf Med       Date:  2007       Impact factor: 2.176

4.  Partial volume effect correction in PET using regularized iterative deconvolution with variance control based on local topology.

Authors:  A S Kirov; J Z Piao; C R Schmidtlein
Journal:  Phys Med Biol       Date:  2008-04-25       Impact factor: 3.609

5.  18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Authors:  Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

Review 6.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

7.  Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data.

Authors:  Boon-Keng Teo; Youngho Seo; Stephen L Bacharach; Jorge A Carrasquillo; Steven K Libutti; Himanshu Shukla; Bruce H Hasegawa; Randall A Hawkins; Benjamin L Franc
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

8.  Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging.

Authors:  N Boussion; C Cheze Le Rest; M Hatt; D Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-18       Impact factor: 9.236

9.  Functional and structural synergy for resolution recovery and partial volume correction in brain PET.

Authors:  Miho Shidahara; Charalampos Tsoumpas; Alexander Hammers; Nicolas Boussion; Dimitris Visvikis; Tetsuya Suhara; Iwao Kanno; Federico E Turkheimer
Journal:  Neuroimage       Date:  2008-09-25       Impact factor: 6.556

10.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Yi Li; Juha O Rinne; Lisa Mosconi; Elizabeth Pirraglia; Henry Rusinek; Susan DeSanti; Nina Kemppainen; Kjell Någren; Byeong-Chae Kim; Wai Tsui; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-20       Impact factor: 9.236

View more
  112 in total

1.  Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?

Authors:  Mateen C Moghbel; Babak Saboury; Sandip Basu; Scott D Metzler; Drew A Torigian; Bengt Långström; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

2.  Anatomical-based partial volume correction for low-dose dedicated cardiac SPECT/CT.

Authors:  Hui Liu; Chung Chan; Yariv Grobshtein; Tianyu Ma; Yaqiang Liu; Shi Wang; Mitchel R Stacy; Albert J Sinusas; Chi Liu
Journal:  Phys Med Biol       Date:  2015-08-21       Impact factor: 3.609

3.  Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysis.

Authors:  Kerstin Heurling; Christopher Buckley; Rik Vandenberghe; Koen Van Laere; Mark Lubberink
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

Review 4.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

5.  Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging.

Authors:  Douglas N Greve; David H Salat; Spencer L Bowen; David Izquierdo-Garcia; Aaron P Schultz; Ciprian Catana; J Alex Becker; Claus Svarer; Gitte M Knudsen; Reisa A Sperling; Keith A Johnson
Journal:  Neuroimage       Date:  2016-02-23       Impact factor: 6.556

6.  Joint solution for PET image segmentation, denoising, and partial volume correction.

Authors:  Ziyue Xu; Mingchen Gao; Georgios Z Papadakis; Brian Luna; Sanjay Jain; Daniel J Mollura; Ulas Bagci
Journal:  Med Image Anal       Date:  2018-03-28       Impact factor: 8.545

7.  Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).

Authors:  Zhihao Zha; Seok Rye Choi; Karl Ploessl; Brian P Lieberman; Wenchao Qu; Franz Hefti; Mark Mintun; Daniel Skovronsky; Hank F Kung
Journal:  J Med Chem       Date:  2011-11-09       Impact factor: 7.446

8.  In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography.

Authors:  Christine Bastin; Mohamed Ali Bahri; François Meyer; Marine Manard; Emma Delhaye; Alain Plenevaux; Guillaume Becker; Alain Seret; Christine Mella; Fabrice Giacomelli; Christian Degueldre; Evelyne Balteau; André Luxen; Eric Salmon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-29       Impact factor: 9.236

9.  Partial volume correction in quantitative amyloid imaging.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Daniel S Marcus; Beau M Ances; Randall J Bateman; Nigel J Cairns; Patricia Aldea; Lisa Cash; Jon J Christensen; Karl Friedrichsen; Russ C Hornbeck; Angela M Farrar; Christopher J Owen; Richard Mayeux; Adam M Brickman; William Klunk; Julie C Price; Paul M Thompson; Bernadino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Peter R Schofield; Virginia Buckles; John C Morris; Tammie L S Benzinger
Journal:  Neuroimage       Date:  2014-12-05       Impact factor: 6.556

10.  Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.

Authors:  Jacques-Antoine Maisonobe; Camilo A Garcia; Hatem Necib; Bruno Vanderlinden; Alain Hendlisz; Patrick Flamen; Irène Buvat
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.